ANI Pharmaceuticals, Inc. (ANIP) Presents at Morgan Stanley 23rd Annual Global

Question-and-Answer SessionWith that, we can begin. We are pleased to host Nikhil Lalwani, CEO of ANI Pharmaceuticals with us today. Nikhil, why don't we start out by -- maybe if you can just give us a high-level overview of each of your businesses. You have multiple businesses under the ANI Pharmaceuticals umbrella. Talk about the different drivers in each segment and how investors should think about growth in those segments.Nikhil LalwaniPresident, CEO & Director Thank you, Daniel, and good afternoon, eve ...